{"variationId": "97006", "variationName": "NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs)", "variationType": "Deletion", "dateCreated": "2014-05-05T00:00:00Z", "dateLastUpdated": "2024-05-01T00:00:00Z", "mostRecentSubmission": "2024-03-05T00:00:00Z", "accession": "VCV000097006", "version": 3, "numberOfSubmitters": 3, "numberOfSubmissions": 7, "recordType": "RECORD_TYPE_CLASSIFIED", "recordStatus": "RECORD_STATUS_CURRENT", "species": {"name": "Homo sapiens"}, "classifiedRecord": {"simpleAllele": {"genes": [{"locations": [{"cytogeneticLocations": ["19p13.13"], "sequenceLocations": [{"assembly": "GRCh38", "chr": "CHROMOSOME_19", "accession": "NC_000019.10", "start": 12938609, "stop": 12944489, "displayStart": 12938609, "displayStop": 12944489, "strand": "+"}, {"assembly": "GRCh37", "chr": "CHROMOSOME_19", "accession": "NC_000019.9", "start": 13049413, "stop": 13055303, "displayStart": 13049413, "displayStop": 13055303, "strand": "+"}]}], "omims": ["109091"], "fullName": "calreticulin", "geneId": "811", "hgncId": "HGNC:1455", "source": "submitted", "relationshipType": "GENE_VARIANT_RELATIONSHIP_WITHIN_SINGLE_GENE"}], "name": "NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs)", "variantTypes": ["Deletion"], "locations": [{"cytogeneticLocations": ["19p13.13"], "sequenceLocations": [{"forDisplay": true, "assembly": "GRCh38", "chr": "CHROMOSOME_19", "accession": "NC_000019.10", "start": 12943751, "stop": 12943802, "displayStart": 12943751, "displayStop": 12943802, "variantLength": 52, "positionVcf": 12943750, "referenceAlleleVcf": "AGCAGAGGCTTAAGGAGGAGGAAGAAGACAAGAAACGCAAAGAGGAGGAGGAG", "alternateAlleleVcf": "A"}, {"assembly": "GRCh37", "chr": "CHROMOSOME_19", "accession": "NC_000019.9", "start": 13054565, "stop": 13054616, "displayStart": 13054565, "displayStop": 13054616, "variantLength": 52, "positionVcf": 13054564, "referenceAlleleVcf": "AGCAGAGGCTTAAGGAGGAGGAAGAAGACAAGAAACGCAAAGAGGAGGAGGAG", "alternateAlleleVcf": "A"}]}], "proteinChanges": ["L367fs"], "hgvsExpressions": [{"nucleotideExpression": {"expression": "NC_000019.10:g.12943758_12943809del", "sequenceAccessionVersion": "NC_000019.10", "sequenceAccession": "NC_000019", "sequenceVersion": 10, "change": "g.12943758_12943809del"}, "type": "HGVS_TYPE_GENOMIC_TOP_LEVEL", "assembly": "GRCh38"}, {"nucleotideExpression": {"expression": "NC_000019.9:g.13054572_13054623del", "sequenceAccessionVersion": "NC_000019.9", "sequenceAccession": "NC_000019", "sequenceVersion": 9, "change": "g.13054572_13054623del"}, "type": "HGVS_TYPE_GENOMIC_TOP_LEVEL", "assembly": "GRCh37"}, {"nucleotideExpression": {"expression": "NG_029662.1:g.10159_10210del", "sequenceAccessionVersion": "NG_029662.1", "sequenceAccession": "NG_029662", "sequenceVersion": 1, "change": "g.10159_10210del"}, "type": "HGVS_TYPE_GENOMIC"}, {"nucleotideExpression": {"expression": "NM_004343.4:c.1099_1150del", "sequenceAccessionVersion": "NM_004343.4", "sequenceAccession": "NM_004343", "sequenceVersion": 4, "change": "c.1099_1150del", "maneSelect": true}, "proteinExpression": {"expression": "NP_004334.1:p.Leu367fs", "sequenceAccessionVersion": "NP_004334.1", "sequenceAccession": "NP_004334", "sequenceVersion": 1, "change": "p.Leu367fs"}, "molecularConsequences": [{"db": "SO", "id": "SO:0001589", "type": "frameshift variant"}], "type": "HGVS_TYPE_CODING"}, {"nucleotideExpression": {"expression": "LRG_828:g.10159_10210del", "sequenceAccessionVersion": "LRG_828", "sequenceAccession": "LRG_828"}, "type": "HGVS_TYPE_GENOMIC"}, {"nucleotideExpression": {"expression": "NM_004343.3:c.1092_1143del52", "sequenceAccessionVersion": "NM_004343.3", "sequenceAccession": "NM_004343", "sequenceVersion": 3, "change": "c.1092_1143del52"}, "type": "HGVS_TYPE_CODING"}], "xrefs": [{"db": "ClinGen", "id": "CA149708"}, {"db": "dbVar", "id": "nssv3761626"}, {"db": "dbVar", "id": "nsv1067850"}, {"db": "OMIM", "id": "109091.0001", "type": "Allelic variant"}, {"db": "dbSNP", "id": "1555760738", "type": "rs"}], "comments": [{"value": "52-nt deletion from exon 9 of CALR.", "dataSource": "NCBI curation", "type": "COMMENT_TYPE_PUBLIC"}], "alleleId": "102915", "variationId": "97006"}, "rcvList": {"rcvAccessions": [{"classifiedConditionList": {"classifiedConditions": [{"value": "Primary myelofibrosis", "db": "MedGen", "id": "C0001815"}], "traitSetId": "6477"}, "rcvClassifications": {"germlineClassification": {"reviewStatus": "AGGREGATE_GERMLINE_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "description": {"value": "Pathogenic", "dateLastEvaluated": "2013-12-19T00:00:00Z", "submissionCount": 1}}}, "title": "NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs) AND Primary myelofibrosis", "accession": "RCV000083256", "version": 5}, {"classifiedConditionList": {"classifiedConditions": [{"value": "Thrombocythemia 1", "db": "MedGen", "id": "C3277671"}], "traitSetId": "2608"}, "rcvClassifications": {"germlineClassification": {"reviewStatus": "AGGREGATE_GERMLINE_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "description": {"value": "Pathogenic", "dateLastEvaluated": "2013-12-19T00:00:00Z", "submissionCount": 1}}}, "title": "NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs) AND Thrombocythemia 1", "accession": "RCV000083257", "version": 5}, {"classifiedConditionList": {"classifiedConditions": [{"value": "Primary myelofibrosis", "db": "MedGen", "id": "C0001815"}, {"value": "Thrombocythemia 1", "db": "MedGen", "id": "C3277671"}], "traitSetId": "19309"}, "rcvClassifications": {"germlineClassification": {"reviewStatus": "AGGREGATE_GERMLINE_REVIEW_STATUS_CRITERIA_PROVIDED_SINGLE_SUBMITTER", "description": {"value": "Pathogenic", "dateLastEvaluated": "2022-02-10T00:00:00Z", "submissionCount": 1}}}, "title": "NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs) AND multiple conditions", "accession": "RCV002498437", "version": 1}, {"classifiedConditionList": {"classifiedConditions": [{"value": "Essential thrombocythemia", "db": "MedGen", "id": "C0040028"}], "traitSetId": "22296"}, "rcvClassifications": {"somaticClinicalImpact": {"reviewStatus": "AGGREGATE_SOMATIC_CLINICAL_IMPACT_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "descriptions": [{"value": "Tier I - Strong", "clinicalImpactAssertionType": "diagnostic", "clinicalImpactClinicalSignificance": "supports diagnosis", "dateLastEvaluated": "2024-01-24T00:00:00Z", "submissionCount": 1}, {"value": "Tier I - Strong", "clinicalImpactAssertionType": "prognostic", "clinicalImpactClinicalSignificance": "better outcome", "dateLastEvaluated": "2024-01-24T00:00:00Z", "submissionCount": 1}]}}, "title": "NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs) AND Essential thrombocythemia", "accession": "RCV003883131", "version": 1}, {"classifiedConditionList": {"classifiedConditions": [{"value": "Acute myeloid leukemia", "db": "MedGen", "id": "C0023467"}], "traitSetId": "6288"}, "rcvClassifications": {"somaticClinicalImpact": {"reviewStatus": "AGGREGATE_SOMATIC_CLINICAL_IMPACT_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "descriptions": [{"value": "Tier III - Unknown", "dateLastEvaluated": "2024-01-24T00:00:00Z", "submissionCount": 1}]}, "oncogenicityClassification": {"reviewStatus": "AGGREGATE_ONCOGENICITY_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "description": {"value": "Uncertain significance", "dateLastEvaluated": "2024-01-24T00:00:00Z", "submissionCount": 1}}}, "title": "NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs) AND Acute myeloid leukemia", "accession": "RCV003883130", "version": 1}]}, "classifications": {"germlineClassification": {"reviewStatus": "AGGREGATE_GERMLINE_REVIEW_STATUS_CRITERIA_PROVIDED_SINGLE_SUBMITTER", "description": "Pathogenic", "citations": [{"ids": [{"value": "24325356", "source": "PubMed"}], "type": "general"}, {"ids": [{"value": "24325359", "source": "PubMed"}], "type": "general"}], "conditions": [{"traits": [{"names": [{"value": "THROMBOCYTHEMIA, SOMATIC", "type": "Alternate", "xrefs": [{"db": "OMIM", "id": "109091.0001", "type": "Allelic variant"}, {"db": "OMIM", "id": "605093.0002", "type": "Allelic variant"}]}, {"value": "Idiopathic thrombocythemia", "type": "Alternate"}, {"value": "THROMBOCYTOSIS 1", "type": "Alternate", "xrefs": [{"db": "OMIM", "id": "187950", "type": "MIM"}]}, {"value": "Thrombocythemia 1", "type": "Preferred", "xrefs": [{"db": "MONDO", "id": "MONDO:0008554"}]}], "symbols": [{"value": "THCYT1", "type": "Preferred", "xrefs": [{"db": "OMIM", "id": "187950", "type": "MIM"}]}], "xrefs": [{"db": "MedGen", "id": "C3277671"}, {"db": "MONDO", "id": "MONDO:0008554"}, {"db": "OMIM", "id": "187950", "type": "MIM"}]}], "type": "TYPE_DISEASE", "id": "2608", "contributesToAggregateClassification": false}, {"traits": [{"names": [{"value": "Primary myelofibrosis", "type": "Preferred", "xrefs": [{"db": "MONDO", "id": "MONDO:0009692"}]}, {"value": "Myelofibrosis, somatic", "type": "Alternate"}, {"value": "Suspected idiopathic myelofibrosis", "type": "Alternate"}], "attributes": [{"attribute": {"base": {"integerValue": "8618"}, "type": "GARD id"}, "xrefs": [{"db": "Office of Rare Diseases", "id": "8618"}]}, {"attribute": {"base": {"value": "Hereditary cancer syndrome"}, "type": "keyword"}}], "xrefs": [{"db": "Orphanet", "id": "824"}, {"db": "MedGen", "id": "C0001815"}, {"db": "MeSH", "id": "D055728"}, {"db": "MONDO", "id": "MONDO:0009692"}, {"db": "OMIM", "id": "254450", "type": "MIM"}]}], "type": "TYPE_DISEASE", "id": "6477", "contributesToAggregateClassification": false}, {"traits": [{"names": [{"value": "THROMBOCYTHEMIA, SOMATIC", "type": "Alternate", "xrefs": [{"db": "OMIM", "id": "109091.0001", "type": "Allelic variant"}, {"db": "OMIM", "id": "605093.0002", "type": "Allelic variant"}]}, {"value": "Idiopathic thrombocythemia", "type": "Alternate"}, {"value": "THROMBOCYTOSIS 1", "type": "Alternate", "xrefs": [{"db": "OMIM", "id": "187950", "type": "MIM"}]}, {"value": "Thrombocythemia 1", "type": "Preferred", "xrefs": [{"db": "MONDO", "id": "MONDO:0008554"}]}], "symbols": [{"value": "THCYT1", "type": "Preferred", "xrefs": [{"db": "OMIM", "id": "187950", "type": "MIM"}]}], "xrefs": [{"db": "MedGen", "id": "C3277671"}, {"db": "MONDO", "id": "MONDO:0008554"}, {"db": "OMIM", "id": "187950", "type": "MIM"}]}, {"names": [{"value": "Primary myelofibrosis", "type": "Preferred", "xrefs": [{"db": "MONDO", "id": "MONDO:0009692"}]}, {"value": "Myelofibrosis, somatic", "type": "Alternate"}, {"value": "Suspected idiopathic myelofibrosis", "type": "Alternate"}], "attributes": [{"attribute": {"base": {"integerValue": "8618"}, "type": "GARD id"}, "xrefs": [{"db": "Office of Rare Diseases", "id": "8618"}]}, {"attribute": {"base": {"value": "Hereditary cancer syndrome"}, "type": "keyword"}}], "xrefs": [{"db": "Orphanet", "id": "824"}, {"db": "MedGen", "id": "C0001815"}, {"db": "MeSH", "id": "D055728"}, {"db": "MONDO", "id": "MONDO:0009692"}, {"db": "OMIM", "id": "254450", "type": "MIM"}]}], "type": "TYPE_DISEASE", "id": "19309", "contributesToAggregateClassification": true}], "dateLastEvaluated": "2022-02-10T00:00:00Z", "dateCreated": "2014-05-05T00:00:00Z", "mostRecentSubmission": "2022-12-31T00:00:00Z", "numberOfSubmitters": 2, "numberOfSubmissions": 3}, "somaticClinicalImpact": {"reviewStatus": "AGGREGATE_SOMATIC_CLINICAL_IMPACT_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "description": "Tier I - Strong", "citations": [{"ids": [{"value": "24325356", "source": "PubMed"}], "type": "general"}, {"ids": [{"value": "24325359", "source": "PubMed"}], "type": "general"}], "dateLastEvaluated": "2024-01-24T00:00:00Z", "dateCreated": "2024-03-05T00:00:00Z", "mostRecentSubmission": "2024-03-05T00:00:00Z", "numberOfSubmitters": 1, "numberOfSubmissions": 3}, "oncogenicityClassification": {"reviewStatus": "AGGREGATE_ONCOGENICITY_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "description": "Uncertain significance", "citations": [{"ids": [{"value": "31562135", "source": "PubMed"}], "type": "general"}], "dateLastEvaluated": "2024-01-24T00:00:00Z", "dateCreated": "2024-03-05T00:00:00Z", "mostRecentSubmission": "2024-03-05T00:00:00Z", "numberOfSubmitters": 1, "numberOfSubmissions": 1}}, "clinicalAssertions": [{"clinvarSubmissionId": {"localKey": "109091.0001_THROMBOCYTHEMIA, SOMATIC", "title": "CALR, 52-BP DEL, EX9_THROMBOCYTHEMIA, SOMATIC"}, "clinvarAccession": {"accession": "SCV000115336", "version": 2, "submitterIdentifiers": {"submitterName": "OMIM", "orgId": "3", "orgCategory": "resource"}, "dateUpdated": "2014-05-05T00:00:00Z", "dateCreated": "2014-02-11T00:00:00Z"}, "recordStatus": "RECORD_STATUS_CURRENT", "classifications": {"reviewStatus": "SUBMITTER_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "germlineClassification": "Pathogenic", "dateLastEvaluated": "2013-12-19T00:00:00Z"}, "assertion": "ASSERTION_VARIATION_TO_INCLUDED_DISEASE", "observedIns": [{"sample": {"origin": "ORIGIN_SOMATIC", "species": {"name": "human"}, "affectedStatus": "AFFECTED_STATUS_NOT_PROVIDED"}, "observedData": [{"attributes": [{"base": {"value": "Klampfl et al. (2013) and Nangalia et al. (2013) identified a somatic 52-bp deletion in exon 9 of the CALR gene (1092_1143del) in patients with myeloproliferative neoplasms, including myelofibrosis (254450) and essential thrombocythemia (see 187950). CALR mutations and JAK2 and MPL mutations were mutually exclusive. The 52-bp mutation resulted in frameshift and premature termination (L367fsTer46). Klampfl et al. (2013) identified a total of 36 types of somatic insertion or deletion within exon 9 of CALR, all of which caused a frameshift to the same alternative reading frame and generated a novel C-terminal peptide in the mutant calreticulin. Klampfl et al. (2013) identified insertions or deletions in exon 9 of CALR in 88% of individuals with primary myelofibrosis with nonmutated JAK2 or MPL. The 52-bp deletion accounted for 53% of all cases of mutated CALR among several types of myeloproliferative neoplasm. Overexpression of this mutation resulted in cytokine-independent growth in vitro through the activation of STAT5 (601511). Nangalia et al. (2013) identified 23 patients with myelofibrosis who carried the L367fsTer46 mutation. Overall, Nangalia et al. (2013) identified 19 different somatic CALR mutations, all in exon 9 and all of which generated a +1 frameshift resulting in a mutant protein with a novel C terminal. CALR mutations were present in 18 of 32 patients (56%) with primary myelofibrosis and in 12 of 14 patients (86%) with progression of essential thrombocythemia to myelofibrosis. Neither Klampfl et al. (2013) nor Nangalia et al. (2013) detected CALR mutation in individuals with polycythemia vera."}, "type": "TYPE_DESCRIPTION"}], "citations": [{"ids": [{"value": "24325356", "source": "PubMed"}]}, {"ids": [{"value": "24325359", "source": "PubMed"}]}], "xrefs": [{"db": "OMIM", "id": "254450", "type": "MIM"}, {"db": "OMIM", "id": "187950", "type": "MIM"}, {"db": "OMIM", "id": "601511", "type": "MIM"}]}]}], "simpleAllele": {"genes": [{"symbol": "CALR"}], "name": {"value": "CALR, 52-BP DEL, EX9"}, "variantType": "Variation", "otherNames": [{"value": "52-BP DEL, EX9", "type": "NonHGVS"}], "xrefs": [{"db": "OMIM", "id": "109091.0001", "type": "Allelic variant"}]}, "traitSet": {"traits": [{"names": [{"value": "THROMBOCYTHEMIA, SOMATIC", "type": "included"}]}], "type": "TYPE_DISEASE"}, "id": "202976"}, {"clinvarSubmissionId": {"localKey": "109091.0001_MYELOFIBROSIS, SOMATIC", "title": "CALR, 52-BP DEL, EX9_MYELOFIBROSIS, SOMATIC"}, "clinvarAccession": {"accession": "SCV000115335", "version": 2, "submitterIdentifiers": {"submitterName": "OMIM", "orgId": "3", "orgCategory": "resource"}, "dateUpdated": "2014-05-05T00:00:00Z", "dateCreated": "2014-02-11T00:00:00Z"}, "recordStatus": "RECORD_STATUS_CURRENT", "classifications": {"reviewStatus": "SUBMITTER_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "germlineClassification": "Pathogenic", "dateLastEvaluated": "2013-12-19T00:00:00Z"}, "assertion": "ASSERTION_VARIATION_TO_DISEASE", "observedIns": [{"sample": {"origin": "ORIGIN_SOMATIC", "species": {"name": "human"}, "affectedStatus": "AFFECTED_STATUS_NOT_PROVIDED"}, "observedData": [{"attributes": [{"base": {"value": "Klampfl et al. (2013) and Nangalia et al. (2013) identified a somatic 52-bp deletion in exon 9 of the CALR gene (1092_1143del) in patients with myeloproliferative neoplasms, including myelofibrosis (254450) and essential thrombocythemia (see 187950). CALR mutations and JAK2 and MPL mutations were mutually exclusive. The 52-bp mutation resulted in frameshift and premature termination (L367fsTer46). Klampfl et al. (2013) identified a total of 36 types of somatic insertion or deletion within exon 9 of CALR, all of which caused a frameshift to the same alternative reading frame and generated a novel C-terminal peptide in the mutant calreticulin. Klampfl et al. (2013) identified insertions or deletions in exon 9 of CALR in 88% of individuals with primary myelofibrosis with nonmutated JAK2 or MPL. The 52-bp deletion accounted for 53% of all cases of mutated CALR among several types of myeloproliferative neoplasm. Overexpression of this mutation resulted in cytokine-independent growth in vitro through the activation of STAT5 (601511). Nangalia et al. (2013) identified 23 patients with myelofibrosis who carried the L367fsTer46 mutation. Overall, Nangalia et al. (2013) identified 19 different somatic CALR mutations, all in exon 9 and all of which generated a +1 frameshift resulting in a mutant protein with a novel C terminal. CALR mutations were present in 18 of 32 patients (56%) with primary myelofibrosis and in 12 of 14 patients (86%) with progression of essential thrombocythemia to myelofibrosis. Neither Klampfl et al. (2013) nor Nangalia et al. (2013) detected CALR mutation in individuals with polycythemia vera."}, "type": "TYPE_DESCRIPTION"}], "citations": [{"ids": [{"value": "24325356", "source": "PubMed"}]}, {"ids": [{"value": "24325359", "source": "PubMed"}]}], "xrefs": [{"db": "OMIM", "id": "254450", "type": "MIM"}, {"db": "OMIM", "id": "187950", "type": "MIM"}, {"db": "OMIM", "id": "601511", "type": "MIM"}]}]}], "simpleAllele": {"genes": [{"symbol": "CALR"}], "name": {"value": "CALR, 52-BP DEL, EX9"}, "variantType": "Variation", "otherNames": [{"value": "52-BP DEL, EX9", "type": "NonHGVS"}], "xrefs": [{"db": "OMIM", "id": "109091.0001", "type": "Allelic variant"}]}, "traitSet": {"traits": [{"names": [{"value": "MYELOFIBROSIS, SOMATIC", "type": "Preferred"}]}], "type": "TYPE_DISEASE"}, "id": "202975"}, {"clinvarSubmissionId": {"localKey": "NM_004343.4:c.1099_1150del|OMIM:187950;254450", "submittedAssembly": "GRCh37"}, "clinvarAccession": {"accession": "SCV002812646", "version": 1, "submitterIdentifiers": {"submitterName": "Fulgent Genetics, Fulgent Genetics", "orgId": "500105", "orgCategory": "laboratory"}, "dateUpdated": "2022-12-31T00:00:00Z", "dateCreated": "2022-12-31T00:00:00Z"}, "recordStatus": "RECORD_STATUS_CURRENT", "classifications": {"reviewStatus": "SUBMITTER_REVIEW_STATUS_CRITERIA_PROVIDED_SINGLE_SUBMITTER", "germlineClassification": "Pathogenic", "dateLastEvaluated": "2022-02-10T00:00:00Z"}, "assertion": "ASSERTION_VARIATION_TO_DISEASE", "attributes": [{"attribute": {"value": "ACMG Guidelines, 2015"}, "type": "TYPE_ASSERTION_METHOD", "citations": [{"ids": [{"value": "25741868", "source": "PubMed"}]}]}], "observedIns": [{"sample": {"origin": "ORIGIN_UNKNOWN", "species": {"name": "human", "taxonomyId": 9606}, "affectedStatus": "AFFECTED_STATUS_UNKNOWN"}, "observedData": [{"attributes": [{"base": {"value": "not provided"}, "type": "TYPE_DESCRIPTION"}]}]}], "simpleAllele": {"variantType": "Variation", "attributes": [{"attribute": {"base": {"value": "NM_004343.4:c.1099_1150del"}, "type": "HGVS"}}]}, "traitSet": {"traits": [{"xrefs": [{"db": "OMIM", "id": "187950", "type": "MIM"}]}, {"xrefs": [{"db": "OMIM", "id": "254450", "type": "MIM"}]}], "type": "TYPE_TRAIT_CHOICE"}, "submissionNames": ["SUB12390657"], "id": "5461412"}, {"clinvarSubmissionId": {"localKey": "NM_004343.3:c.1092_1143del52|MeSH:D015470|OncogenicityClassification", "submittedAssembly": "GRCh37"}, "clinvarAccession": {"accession": "SCV004697530", "version": 1, "submitterIdentifiers": {"submitterName": "Molecular Diagnostics Laboratory, Fox Chase Cancer Center - Temple Health", "orgId": "509422", "orgCategory": "laboratory"}, "dateUpdated": "2024-03-05T00:00:00Z", "dateCreated": "2024-03-05T00:00:00Z"}, "recordStatus": "RECORD_STATUS_CURRENT", "classifications": {"reviewStatus": "SUBMITTER_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "oncogenicityClassification": "Uncertain significance", "citations": [{"ids": [{"value": "31562135", "source": "PubMed"}]}], "comments": [{"value": "While there are strong associations of this variant to thrombocythemia and myeloproliferative neoplasms, its oncogenicity and clinical impact in this case of acute myeloid leukemia is uncertain because the allele frequency decreased over time from 11% (progressive thrombocythemia) to 3% (AML in remission) to undetectable at AML relapse."}], "dateLastEvaluated": "2024-01-24T00:00:00Z"}, "assertion": "ASSERTION_VARIATION_TO_DISEASE", "observedIns": [{"sample": {"origin": "ORIGIN_SOMATIC", "tissue": "bone marrow with 37% blasts", "somaticVariantInNormalTissue": "SOMATIC_VARIANT_IN_NORMAL_TISSUE_NOT_TESTED", "somaticVariantAlleleFraction": "3%", "species": {"name": "human", "taxonomyId": 9606}, "ages": [{"value": 70, "unit": "AGE_UNIT_YEARS", "type": "AGE_TYPE_MINIMUM"}, {"value": 79, "unit": "AGE_UNIT_YEARS", "type": "AGE_TYPE_MAXIMUM"}], "affectedStatus": "AFFECTED_STATUS_YES", "numerTested": 1, "gender": "GENDER_FEMALE"}, "observedData": [{"attributes": [{"base": {"value": "not provided"}, "type": "TYPE_DESCRIPTION"}]}], "traitSet": {"traits": [{"xrefs": [{"db": "HP", "id": "HP:0031020"}]}, {"xrefs": [{"db": "HP", "id": "HP:0012138"}]}], "type": "TYPE_FINDING", "dateLastEvaluated": "2021-10-15T00:00:00Z"}}], "simpleAllele": {"genes": [{"symbol": "CALR"}], "variantType": "Variation", "attributes": [{"attribute": {"base": {"value": "NM_004343.3:c.1092_1143del52"}, "type": "HGVS"}}]}, "traitSet": {"traits": [{"xrefs": [{"db": "MeSH", "id": "D015470"}]}], "type": "TYPE_DISEASE"}, "submissionNames": ["SUB14244255"], "id": "8771190"}, {"clinvarSubmissionId": {"localKey": "NM_004343.3:c.1092_1143del52|MeSH:D013920|ClinicalImpactClassification|diagnostic", "submittedAssembly": "GRCh37"}, "clinvarAccession": {"accession": "SCV004697527", "version": 1, "submitterIdentifiers": {"submitterName": "Molecular Diagnostics Laboratory, Fox Chase Cancer Center - Temple Health", "orgId": "509422", "orgCategory": "laboratory"}, "dateUpdated": "2024-03-05T00:00:00Z", "dateCreated": "2024-03-05T00:00:00Z"}, "recordStatus": "RECORD_STATUS_CURRENT", "classifications": {"reviewStatus": "SUBMITTER_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "somaticClinicalImpact": {"value": "Tier I - Strong", "clinicalImpactAssertionType": "diagnostic", "clinicalImpactClinicalSignificance": "supports diagnosis"}, "citations": [{"ids": [{"value": "24325359", "source": "PubMed"}]}, {"ids": [{"value": "24325356", "source": "PubMed"}]}], "comments": [{"value": "A large majority of myeloproliferative neoplasms with nonmutated JAK2 exhibit somatic CALR mutations. In a subset of such cases with essential thrombocythemia, 67% had CALR mutation."}], "dateLastEvaluated": "2024-01-24T00:00:00Z"}, "assertion": "ASSERTION_VARIATION_TO_DISEASE", "observedIns": [{"sample": {"origin": "ORIGIN_SOMATIC", "tissue": "bone marrow with ET and 5-9% blasts", "somaticVariantInNormalTissue": "SOMATIC_VARIANT_IN_NORMAL_TISSUE_NOT_TESTED", "somaticVariantAlleleFraction": "11%", "species": {"name": "human", "taxonomyId": 9606}, "ages": [{"value": 70, "unit": "AGE_UNIT_YEARS", "type": "AGE_TYPE_MINIMUM"}, {"value": 79, "unit": "AGE_UNIT_YEARS", "type": "AGE_TYPE_MAXIMUM"}], "affectedStatus": "AFFECTED_STATUS_YES", "numerTested": 1, "gender": "GENDER_FEMALE"}, "observedData": [{"attributes": [{"base": {"value": "not provided"}, "type": "TYPE_DESCRIPTION"}]}], "traitSet": {"traits": [{"xrefs": [{"db": "HP", "id": "HP:0031020"}]}], "type": "TYPE_FINDING", "dateLastEvaluated": "2021-04-15T00:00:00Z"}, "comments": [{"value": "A patient with a 10-year history of elevated and increasing platelet counts had a bone marrow biopsy in the absence of symptoms. The biopsy revealed thrombocythemia, with normal cytogenetics and without mutation of JAK2. CALR was not tested at that time. Approximately 2 \u00bd years later, a second BM biopsy was performed when the patient began having symptoms and counts were worsening. The biopsy had hypercellular marrow with 5-9% blasts and normal karyotype, but revealed this CALR exon 9 mutation at 11% allele frequency. She was started on 5-azyctadine; however, five months later, a BM biopsy showed 37% blasts positive for CD33, CD34, CD117, and HLA-DR, consistent with acute myeloid leukemia, and the karyotype included a novel translocation, t(4;7)(q12;q21.2), in 17 of 20 metaphase spreads examined. After induction chemotherapy with cytarabine and daunorubicin, a day-14 biopsy showed response to therapy, with a hypercellular marrow (80%) that displayed panmyelosis (trilineage hyperplasia), granulocytic hyperplasia, and megakaryocytic atypia without an increase in blasts, consistent with residual/persistent myeloid disease. A PB specimen revealed normocytic normochromatic anemia, leukocytosis, and thrombocytosis. Chromosome microarray analysis and NGS of DNA from a BM sample revealed no detectable genomic imbalances, the CALR deletion at 3.2% allele frequency, and no other pathogenic variants. After eight months in remission, the AML relapsed with blood DNA showing oncogenic somatic mutations at around 50% allele frequency, but no evidence of the CALR deletion."}]}], "simpleAllele": {"genes": [{"symbol": "CALR"}], "variantType": "Variation", "attributes": [{"attribute": {"base": {"value": "NM_004343.3:c.1092_1143del52"}, "type": "HGVS"}}]}, "traitSet": {"traits": [{"xrefs": [{"db": "MeSH", "id": "D013920"}]}], "type": "TYPE_FINDING"}, "submissionNames": ["SUB14244255"], "id": "8771187"}, {"clinvarSubmissionId": {"localKey": "NM_004343.3:c.1092_1143del52|MeSH:D013920|ClinicalImpactClassification|prognostic", "submittedAssembly": "GRCh37"}, "clinvarAccession": {"accession": "SCV004697528", "version": 1, "submitterIdentifiers": {"submitterName": "Molecular Diagnostics Laboratory, Fox Chase Cancer Center - Temple Health", "orgId": "509422", "orgCategory": "laboratory"}, "dateUpdated": "2024-03-05T00:00:00Z", "dateCreated": "2024-03-05T00:00:00Z"}, "recordStatus": "RECORD_STATUS_CURRENT", "classifications": {"reviewStatus": "SUBMITTER_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "somaticClinicalImpact": {"value": "Tier I - Strong", "clinicalImpactAssertionType": "prognostic", "clinicalImpactClinicalSignificance": "better outcome"}, "citations": [{"ids": [{"value": "24325356", "source": "PubMed"}]}], "comments": [{"value": "In a cohort of 1107 myeloproliferative neoplasm patients, those with \"mutated CALR had a lower risk of thromobsis and longer overall survival than patients with mutated JAK2.\""}], "dateLastEvaluated": "2024-01-24T00:00:00Z"}, "assertion": "ASSERTION_VARIATION_TO_DISEASE", "observedIns": [{"sample": {"origin": "ORIGIN_SOMATIC", "tissue": "bone marrow with ET and 5-9% blasts", "somaticVariantInNormalTissue": "SOMATIC_VARIANT_IN_NORMAL_TISSUE_NOT_TESTED", "somaticVariantAlleleFraction": "11%", "species": {"name": "human", "taxonomyId": 9606}, "ages": [{"value": 70, "unit": "AGE_UNIT_YEARS", "type": "AGE_TYPE_MINIMUM"}, {"value": 79, "unit": "AGE_UNIT_YEARS", "type": "AGE_TYPE_MAXIMUM"}], "affectedStatus": "AFFECTED_STATUS_YES", "numerTested": 1, "gender": "GENDER_FEMALE"}, "observedData": [{"attributes": [{"base": {"value": "not provided"}, "type": "TYPE_DESCRIPTION"}]}], "traitSet": {"traits": [{"xrefs": [{"db": "HP", "id": "HP:0031020"}]}], "type": "TYPE_FINDING", "dateLastEvaluated": "2021-04-15T00:00:00Z"}}], "simpleAllele": {"genes": [{"symbol": "CALR"}], "variantType": "Variation", "attributes": [{"attribute": {"base": {"value": "NM_004343.3:c.1092_1143del52"}, "type": "HGVS"}}]}, "traitSet": {"traits": [{"xrefs": [{"db": "MeSH", "id": "D013920"}]}], "type": "TYPE_FINDING"}, "submissionNames": ["SUB14244255"], "id": "8771188"}, {"clinvarSubmissionId": {"localKey": "NM_004343.3:c.1092_1143del52|MeSH:D015470|ClinicalImpactClassification", "submittedAssembly": "GRCh37"}, "clinvarAccession": {"accession": "SCV004697529", "version": 1, "submitterIdentifiers": {"submitterName": "Molecular Diagnostics Laboratory, Fox Chase Cancer Center - Temple Health", "orgId": "509422", "orgCategory": "laboratory"}, "dateUpdated": "2024-03-05T00:00:00Z", "dateCreated": "2024-03-05T00:00:00Z"}, "recordStatus": "RECORD_STATUS_CURRENT", "classifications": {"reviewStatus": "SUBMITTER_REVIEW_STATUS_NO_ASSERTION_CRITERIA_PROVIDED", "somaticClinicalImpact": {"value": "Tier III - Unknown"}, "comments": [{"value": "While there are strong associations of this variant to thrombocythemia and myeloproliferative neoplasms, its oncogenicity and clinical impact in this case of acute myeloid leukemia is uncertain because the allele frequency decreased over time from 11% (progressive thrombocythemia) to 3% (AML in remission) to undetectable at AML relapse."}], "dateLastEvaluated": "2024-01-24T00:00:00Z"}, "assertion": "ASSERTION_VARIATION_TO_DISEASE", "observedIns": [{"sample": {"origin": "ORIGIN_SOMATIC", "tissue": "bone marrow with 37% blasts", "somaticVariantInNormalTissue": "SOMATIC_VARIANT_IN_NORMAL_TISSUE_NOT_TESTED", "somaticVariantAlleleFraction": "3%", "species": {"name": "human", "taxonomyId": 9606}, "ages": [{"value": 70, "unit": "AGE_UNIT_YEARS", "type": "AGE_TYPE_MINIMUM"}, {"value": 79, "unit": "AGE_UNIT_YEARS", "type": "AGE_TYPE_MAXIMUM"}], "affectedStatus": "AFFECTED_STATUS_YES", "numerTested": 1, "gender": "GENDER_FEMALE"}, "observedData": [{"attributes": [{"base": {"value": "not provided"}, "type": "TYPE_DESCRIPTION"}]}], "traitSet": {"traits": [{"xrefs": [{"db": "HP", "id": "HP:0031020"}]}, {"xrefs": [{"db": "HP", "id": "HP:0012138"}]}], "type": "TYPE_FINDING", "dateLastEvaluated": "2021-10-15T00:00:00Z"}}], "simpleAllele": {"genes": [{"symbol": "CALR"}], "variantType": "Variation", "attributes": [{"attribute": {"base": {"value": "NM_004343.3:c.1092_1143del52"}, "type": "HGVS"}}]}, "traitSet": {"traits": [{"xrefs": [{"db": "MeSH", "id": "D015470"}]}], "type": "TYPE_DISEASE"}, "submissionNames": ["SUB14244255"], "id": "8771189"}], "traitMappings": [{"medgens": [{"name": "Acute myeloid leukemia", "cui": "C0023467"}], "clinicalAssertionId": "8771189", "traitType": "Disease", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "D015470", "mappingRef": "MeSH"}, {"medgens": [{"name": "Granulocytic hyperplasia", "cui": "C4023028"}], "clinicalAssertionId": "8771190", "traitType": "Finding", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "HP:0012138", "mappingRef": "HP"}, {"medgens": [{"name": "Thrombocythemia 1", "cui": "C3277671"}], "clinicalAssertionId": "5461412", "traitType": "Disease", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "187950", "mappingRef": "OMIM"}, {"medgens": [{"name": "Bone marrow hypercellularity", "cui": "C0427703"}], "clinicalAssertionId": "8771188", "traitType": "Finding", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "HP:0031020", "mappingRef": "HP"}, {"medgens": [{"name": "Primary myelofibrosis", "cui": "C0001815"}], "clinicalAssertionId": "5461412", "traitType": "Disease", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "254450", "mappingRef": "OMIM"}, {"medgens": [{"name": "Essential thrombocythemia", "cui": "C0040028"}], "clinicalAssertionId": "8771187", "traitType": "Finding", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "D013920", "mappingRef": "MeSH"}, {"medgens": [{"name": "Essential thrombocythemia", "cui": "C0040028"}], "clinicalAssertionId": "8771188", "traitType": "Finding", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "D013920", "mappingRef": "MeSH"}, {"medgens": [{"name": "Bone marrow hypercellularity", "cui": "C0427703"}], "clinicalAssertionId": "8771190", "traitType": "Finding", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "HP:0031020", "mappingRef": "HP"}, {"medgens": [{"name": "Bone marrow hypercellularity", "cui": "C0427703"}], "clinicalAssertionId": "8771187", "traitType": "Finding", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "HP:0031020", "mappingRef": "HP"}, {"medgens": [{"name": "Bone marrow hypercellularity", "cui": "C0427703"}], "clinicalAssertionId": "8771189", "traitType": "Finding", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "HP:0031020", "mappingRef": "HP"}, {"medgens": [{"name": "Thrombocythemia 1", "cui": "C3277671"}], "clinicalAssertionId": "202976", "traitType": "Disease", "mappingType": "MAPPING_TYPE_NAME", "mappingValue": "THROMBOCYTHEMIA, SOMATIC", "mappingRef": "Alternate"}, {"medgens": [{"name": "Acute myeloid leukemia", "cui": "C0023467"}], "clinicalAssertionId": "8771190", "traitType": "Disease", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "D015470", "mappingRef": "MeSH"}, {"medgens": [{"name": "Granulocytic hyperplasia", "cui": "C4023028"}], "clinicalAssertionId": "8771189", "traitType": "Finding", "mappingType": "MAPPING_TYPE_XREF", "mappingValue": "HP:0012138", "mappingRef": "HP"}, {"medgens": [{"name": "Primary myelofibrosis", "cui": "C0001815"}], "clinicalAssertionId": "202975", "traitType": "Disease", "mappingType": "MAPPING_TYPE_NAME", "mappingValue": "MYELOFIBROSIS, SOMATIC", "mappingRef": "Preferred"}]}}
